Documents
Application Sponsors
ANDA 077571 | SUN PHARM INDS INC | |
Marketing Status
None (Tentative Approval) | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET; ORAL | 0.5MG | 0 | REPAGLINIDE | REPAGLINIDE |
002 | TABLET;ORAL | 1MG | 0 | REPAGLINIDE | REPAGLINIDE |
003 | TABLET;ORAL | 2MG | 0 | REPAGLINIDE | REPAGLINIDE |
FDA Submissions
| ORIG | 1 | AP | 2013-07-11 | |
LABELING; Labeling | SUPPL | 8 | AP | 2019-10-01 | STANDARD |
LABELING; Labeling | SUPPL | 12 | AP | 2019-10-01 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 8 | Null | 15 |
SUPPL | 12 | Null | 15 |
TE Codes
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
SUN PHARM INDS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 77571
[companyName] => SUN PHARM INDS INC
[docInserts] => ["",""]
[products] => [{"drugName":"REPAGLINIDE","activeIngredients":"REPAGLINIDE","strength":"0.5MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"REPAGLINIDE","activeIngredients":"REPAGLINIDE","strength":"1MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"REPAGLINIDE","activeIngredients":"REPAGLINIDE","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"07\/11\/2013","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/077571s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"REPAGLINIDE","submission":"REPAGLINIDE","actionType":"0.5MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"},{"actionDate":"REPAGLINIDE","submission":"REPAGLINIDE","actionType":"1MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"REPAGLINIDE","submission":"REPAGLINIDE","actionType":"2MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2013-07-11
)
)